Marinus製藥 MRNS 深 滬
已收盤 09-06 16:00:00 美东时间
1.40
+0.010
+0.72%
華盛通- 最 高1.43
- 今 開1.39
- 成交量 27.16万股
- 最 低 1.34
- 昨 收 1.39
- 總市值 7644.00万
- 52周最高 11.26
- 市盈率 靜 --
- 換手率 0.50%
- 52周最低 1.05
- 委 比 -86.18%
- 總股本 5460.00万
- 歷史最高 82.88
- 量 比 0.88
- 振 幅 6.47%
- 歷史最低 1.05
- 每 手 1
- 風險率 3.62%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Ladenburg Thalmann Downgrades Marinus Pharma to Neutral
Ladenburg Thalmann analyst Michael Higgins downgrades Marinus Pharma (NASDAQ:MRNS) from Buy to Neutral.
08-14 19:48
Buy Rating Affirmed on Marinus’s Growth and Ztalmy’s Market Expansion
H.C. Wainwright analyst Douglas Tsao has reiterated their bullish stance on MRN...
08-14 18:18
快讯 | marinus pharmaceuticals营业收入Q2未达预期，股价下跌4%
Marinus Pharmaceuticals Shares Fall 4% After Missing Q2 Revenue Estimates
08-13 21:34
快讯 | Marinus Pharmaceuticals公司- 2024年全年指南保持不变
Marinus Pharmaceuticals Inc - Full Year 2024 Guidance Remains Unchanged
08-13 19:05
快讯 | Marinus Pharmaceuticals提供业务更新并报告2024年第二季度财务业绩。
Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 202...
08-13 19:01
快讯 | marinus pharmaceuticals将于2024年8月13日提供业务更新和报告第二季度财务业绩。
Marinus Pharmaceuticals to Provide Business Update and Report Second Quarter 20...
07-30 20:00
Class Action Lawsuit against Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS)
A class action lawsuit was filed against Marinus Pharmaceuticals, Inc. ($MRNS) ...
07-22 15:23
新浪财经ESG：MRNS 路孚特（Refinitiv）ESG评级调升至C-
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
07-08 07:00
Truist Securities Maintains Buy on Marinus Pharma, Maintains $10 Price Target
Truist Securities analyst Joon Lee maintains Marinus Pharma (NASDAQ:MRNS) with a Buy and maintains $10 price target.
06-19 01:49
Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), PolyPid (PYPD) and Marinus (MRNS)
Analysts have been eager to weigh in on the Healthcare sector with new ratings ...
06-18 18:20
